| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 产品销售(元) | 512,972,960.48 | - | 440,746,501.83 | - | 514,516,463.31 |
| 技术服务(元) | 29,932,547.81 | 25,451,581.02 | 7,521,898.45 | 33,155,520.61 | 13,709,445.41 |
| 奥沙利铂注射液(元) | - | 222,504,400.55 | - | 363,535,751.90 | - |
| 注射用阿扎胞苷(元) | - | 142,256,404.25 | - | 136,683,552.23 | - |
| 注射用培美曲塞二钠(元) | - | 106,464,279.19 | - | 210,921,185.28 | - |
| 其他产品(元) | - | 491,782,099.85 | - | 341,075,360.57 | - |
| 其他(元) | 8,950,671.70 | - | - | - | - |
| 营业成本(元) | |||||
| 产品销售(元) | 89,617,049.77 | - | 73,427,747.66 | - | 83,696,541.35 |
| 技术服务(元) | 16,919,273.25 | 21,450,007.18 | 6,991,069.64 | 20,765,388.09 | 9,893,394.38 |
| 奥沙利铂注射液(元) | - | 24,380,030.22 | - | 25,420,898.53 | - |
| 注射用阿扎胞苷(元) | - | 16,404,849.09 | - | 15,957,243.89 | - |
| 注射用培美曲塞二钠(元) | - | 10,303,038.09 | - | 24,751,928.45 | - |
| 其他产品(元) | - | 127,990,828.84 | - | 93,734,279.44 | - |
| 其他(元) | 21,799,235.78 | - | - | - | - |
| 毛利(元) | |||||
| 产品销售(元) | 423,355,910.71 | - | 367,318,754.17 | - | 430,819,921.96 |
| 技术服务(元) | 13,013,274.56 | 4,001,573.84 | 530,828.81 | 12,390,132.52 | 3,816,051.03 |
| 奥沙利铂注射液(元) | - | 198,124,370.33 | - | 338,114,853.37 | - |
| 注射用阿扎胞苷(元) | - | 125,851,555.16 | - | 120,726,308.34 | - |
| 注射用培美曲塞二钠(元) | - | 96,161,241.10 | - | 186,169,256.83 | - |
| 其他产品(元) | - | 363,791,271.01 | - | 247,341,081.13 | - |
| 其他(元) | -12,848,564.08 | - | - | - | - |
| 毛利率(%) | |||||
| 产品销售(%) | 82.53 | - | 83.34 | - | 83.73 |
| 技术服务(%) | 43.48 | 15.72 | 7.06 | 37.37 | 27.84 |
| 奥沙利铂注射液(%) | - | 89.04 | - | 93.01 | - |
| 注射用阿扎胞苷(%) | - | 88.47 | - | 88.33 | - |
| 注射用培美曲塞二钠(%) | - | 90.32 | - | 88.26 | - |
| 其他产品(%) | - | 73.97 | - | 72.52 | - |
| 其他(%) | -143.55 | - | - | - | - |
| 收入构成(%) | |||||
| 产品销售(%) | 92.95 | - | 98.32 | - | 97.40 |
| 技术服务(%) | 5.42 | 2.57 | 1.68 | 3.05 | 2.60 |
| 奥沙利铂注射液(%) | - | 22.51 | - | 33.49 | - |
| 注射用阿扎胞苷(%) | - | 14.39 | - | 12.59 | - |
| 注射用培美曲塞二钠(%) | - | 10.77 | - | 19.43 | - |
| 其他产品(%) | - | 49.75 | - | 31.42 | - |
| 其他(%) | 1.62 | - | - | - | - |
| 毛利构成(%) | |||||
| 产品销售(%) | 99.96 | - | 99.86 | - | 99.12 |
| 技术服务(%) | 3.07 | 0.51 | 0.14 | 1.37 | 0.88 |
| 奥沙利铂注射液(%) | - | 25.14 | - | 37.37 | - |
| 注射用阿扎胞苷(%) | - | 15.97 | - | 13.34 | - |
| 注射用培美曲塞二钠(%) | - | 12.20 | - | 20.58 | - |
| 其他产品(%) | - | 46.17 | - | 27.34 | - |
| 其他(%) | -3.03 | - | - | - | - |